Published: 2015-02-25
Proceedings
The Evolving Landscape of GI Tumors
Abstract 90 | PDF Downloads 47Page 3
HER-2 and Gastric Cancer
Abstract 78 | PDF Downloads 47Page 5-7
Circulating tumor cells: current challenges and future perspectives
Abstract 88 | PDF Downloads 47Page 11-13
Update in localized rectal cancer
Abstract 66 | PDF Downloads 45Page 14-17
Therapeutic algorithm of pancreatic neuroendocrine neoplasms
Abstract 102 | PDF (Italian) Downloads 46Page 18-20
Neoadjuvant therapy of gastroesophageal junction adenocarcinoma: chemoradiotherapy or chemotherapy
Abstract 103 | PDF Downloads 45Page 21-23
Gastric Cancer: therapeutic choices in advanced disease
Abstract 77 | PDF Downloads 48Page 24-25
S-1 in the treatment of advanced gastric cancer: up-date
Abstract 126 | PDF Downloads 51Page 26-29
Ramucirumab: a new option in advanced gastric cancer
Abstract 78 | PDF Downloads 44Page 30-32
Bevacizumab beyond progression: Pros
Abstract 70 | PDF Downloads 52Page 33-35
The Challenge of anti-EGFR therapy-rechallenge in management of metastatic colorectal cancer
Abstract 117 | PDF Downloads 54Page 36-39
Second line treatment of metastatic colorectal cancer: aflibercept
Abstract 214 |Page 40-44
Resistance to biologic drugs
Abstract 83 | PDF Downloads 47Page 45-46
Monotherapy vs doublet chemotherapy vs Folfirinox: who and why
Abstract 82 | PDF Downloads 50Page 47-49
SPARC and treatment in pancreatic ductal adenocarcinoma: evidences and new challenge for the future
Abstract 103 | PDF Downloads 52Page 50-51
Update on nab-Paclitaxel in the treatment of pancreatic cancer
Abstract 90 | PDF Downloads 52Page 52-54